Tau-mediated synaptic dysfunction in age-related neurodegenerative diseases
Tau-mediated synaptic dysfunction in age-related neurodegenerative diseases
批准号:
10729927
负责人:
Audrey Weber
金额:
$4.07万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-07 至 2025-09-06
关键词:
Action PotentialsAffinityAgeAgingAlzheimer&aposs DiseaseAxonBiochemicalBiochemistryBiologicalBiological ModelsBrainBrain regionCell modelCellsCellular biologyCommunitiesDataDendritesDendritic SpinesDiseaseDisease ProgressionDisease modelElectrophysiology (science)EventExhibitsExperimental DesignsExperimental ModelsExposure toFunctional disorderGlutamate ReceptorGoalsHumanImpaired cognitionLinkMAPT geneMaintenanceMass Spectrum AnalysisMediatingMemoryMethodsMicroscopyMicrotubulesModelingMolecularNerve DegenerationNeurofibrillary TanglesNeuronsPathologicPathologyPathway interactionsPatientsPhasePhenotypePopulationPositioning AttributePostdoctoral FellowProcessProteinsProteomeProteomicsResearchResearch PersonnelSamplingSeveritiesSignal PathwaySpecificityStructureSynapsesTauopathiesTechniquesTemporal LobeTestingTherapeuticTissuesTrainingUniversitiesValidationVertebral columnWorkage relatedage related neurodegenerationaging braincell typecognitive functioncohortdensityentorhinal cortexexperimental studyhuman datahuman diseasehuman modelinterestmorphometrymouse modelmulti-electrode arraysnegative affectnetwork dysfunctionneuronal cell bodynew therapeutic targetnormal agingnovelpostsynapticpre-clinicalpreservationreligious order studyskillssuccesstau Proteinstau aggregationtau mutationtherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neurofibrillary tangles (NFTs) of the microtubule-associated protein tau are a universal feature of the aging brain.
The extent of tau pathology throughout the brain correlates with both synapse loss and severity of cognitive
impairment in age-related tauopathies. The ability to maintain cognitive function with a brain accumulating NFTs
relies on the preservation and maintenance of synaptic networks. Therefore, understanding the mechanism by
which tau contributes to network and synapse vulnerability is critical for developing preventative therapeutics.
The goal of this proposal is to determine the cellular mechanism(s) by which pathologic tau drives neuronal
network dysfunction. The experiments proposed in this application will uncover these mechanisms and provide
intellectual and technical training for a successful transition into a postdoctoral position. The F99 phase (Aim 1)
will test mechanistic cell biological hypotheses to better define how abnormal tau accumulation induces synaptic
dysfunction, while providing opportunity to develop intricate experimental design and execution skills through
cutting-edge biochemistry, microscopy, and electrophysiology techniques. The K00 phase (Aim 2) will build upon
the F99 studies with computational strategies to integrate proteomics data from humans and experimental
models to identify co-existing molecular changes that are highly relevant to age-related tauopathies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金